XuanZhu Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:XuanZhu Pharma Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10948
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
XuanZhu Pharma Co Ltd (XuanZhu), a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd, is a developer and manufacturer of medicinal products. The company’s products comprise anti-infective drugs apapenem and benapenem; anti-acid drug anaprazole sodium, anti-diabetic drug imigliptin hydrochloride and anti-hypertensive drug tylerdipine hydrochloride. Its technology platforms include drug analysis lab, preparation research lab, lab for crystal form study and salt selection, BSL-2 lab, lab for pharmacokinetics and drug metabolism among others. The company offers products in therapeutic areas of cardiology, oncology, and others. XuanZhu is headquartered in Jinan, China.

XuanZhu Pharma Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
RaQualia Pharma Enters into Research Agreement with XuanZhu Pharma 10
Covance Enters into Co-Development Agreement with Sihuan Pharma 11
Acquisition 12
Sihuan Pharma Acquires 40% Stake in XuanZhu Pharma 12
XuanZhu Pharma Co Ltd – Key Competitors 13
XuanZhu Pharma Co Ltd – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
XuanZhu Pharma Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
RaQualia Pharma Enters into Research Agreement with XuanZhu Pharma 10
Covance Enters into Co-Development Agreement with Sihuan Pharma 11
Sihuan Pharma Acquires 40% Stake in XuanZhu Pharma 12
XuanZhu Pharma Co Ltd, Key Competitors 13

List of Figures
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[XuanZhu Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Staidson (Beijing) Biopharmaceuticals Co Ltd (300204)-製薬・医療分野:企業M&A・提携分析
    Summary Staidson (Beijing) Biopharmaceuticals Co Ltd (Staidson) focuses on the research, development and commercialization of biological protein products. The company’s product portfolio comprises Su peptide Health, an injection of mouse nerve growth factor; Shu Taiqing, Shu Wei Xin, Gliclazide, Nab …
  • eClinicalWorks LLC:企業の戦略的SWOT分析
    eClinicalWorks LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Bukwang Pharm Co Ltd (003000)-製薬・医療分野:企業M&A・提携分析
    Summary Bukwang PharmCo Ltd (BUKWANG) is a pharmaceutical company which develops pharmaceutical products and new drugs. The company’s product portfolio includes levovir, legalon, dexid, thioctacid, lonasen, ixel, Orfil, azeptin, asima among others. Its pipeline products comprise MLR-1023, JM-010, JM …
  • EllisDon Corporation:企業の戦略・SWOT・財務情報
    EllisDon Corporation - Strategy, SWOT and Corporate Finance Report Summary EllisDon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Qantas Airways Ltd (QAN):企業の財務・戦略的SWOT分析
    Qantas Airways Ltd (QAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Core Laboratories NV (CLB):企業の財務・戦略的SWOT分析
    Core Laboratories NV (CLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Vermont Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Vermont Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Bharat Heavy Electricals Limited (BHEL):企業の戦略・SWOT・財務情報
    Bharat Heavy Electricals Limited (BHEL) - Strategy, SWOT and Corporate Finance Report Summary Bharat Heavy Electricals Limited (BHEL) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • P2 Energy Solutions Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary P2 Energy Solutions Inc (P2 Energy), a subsidiary of P2ES Holdings Inc, is an oilfield services company that develops and offers oilfield software solutions. The company provides various tools for environmental, health and safety, finance and accounting, land management and geospatial data, …
  • China Mengniu Dairy Co Ltd:戦略・SWOT・企業財務分析
    China Mengniu Dairy Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Mengniu Dairy Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PCI Biotech Holding ASA (PCIB):企業の財務・戦略的SWOT分析
    Summary PCI Biotech Holding ASA (PCI Biotech) is a biopharmaceutical company that focus on development and commercialisation of novel therapies for the treatment of cancer. The company develops therapeutic products based on its proprietary photochemical internalisation technology. Its lead product c …
  • SonarMed Inc:医療機器:M&Aディール及び事業提携情報
    Summary SonarMed Inc (SonarMed) is a medical device company that develops endotrachael systems used for the inhalation and ventilation assistance patients. The company offers products such as artificial respiratory, endotrachael tubes, biomedical acoustics, SonarMed Airwave, medical devices, disposa …
  • Nordstrom Inc (JWN):企業の財務・戦略的SWOT分析
    Nordstrom Inc (JWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Exelon Generation Company LLC-エネルギー分野:企業M&A・提携分析
    Summary Exelon Generation Company, LLC (Exelon Generation), a subsidiary of Exelon Corporation, generates, transmits and markets electricity. It sells renewable energy and other energy-related products and services. Geographically, it has operations in the Mid-Atlantic, Midwest, New England, New Yor …
  • New Balance Athletic Shoe Inc:企業の戦略的SWOT分析
    New Balance Athletic Shoe Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Zweites Deutsches Fernsehen:企業の戦略的SWOT分析
    Zweites Deutsches Fernsehen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Cortec GmbH:企業の製品パイプライン分析2018
    Summary Cortec GmbH (Cortec), a subsidiary of Iron Force Industrial Co Ltd, is a medical engineering company that develops neurons technology platform for the measurement and stimulation of brain activity. The company develops implants that serve as a direct interface between brain and technology. I …
  • Micro Labs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Micro Labs Ltd (Micro Labs) is a healthcare service organization which conducts research and development of bio equivalent generics. The organization’s business segments include formulations and active pharmaceutical ingredients. Its products include acetamide, allercet, amiodar, amlong, aml …
  • Wesfarmers Ltd (WES)-石油・ガス分野:企業M&A・提携分析
    Summary Wesfarmers Limited (Wesfarmers) is a diversified company that has business operations in retail and industrial activities. Its retail activities include supermarkets, liquor, hotels and convenience stores; department stores; home improvement and office supplies; and apparel retailing. The co …
  • Sinochem Group Co Ltd:企業の戦略的SWOT分析
    Sinochem Group Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆